新冠合并真菌细菌感染专题指南汇总

发布日期: 2023-06-16
关键词:
新冠合并真菌感染,新冠继发真菌感染,新冠合并细菌感染,新冠继发细菌感染,感染科

1. COVID-19时期的抗真菌管理
    The battle against fungi- lessons in antifungal stewardship from COVID-19 times: a consensus statement on behalf of the International Society of Antimicrobial Chemotherapy, Alliance for the Prudent Use of Antibiotics, European Society of Clinical Microbiology and Infectious Diseases Study Group for Antimicrobial Stewardship, and European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group
    [原文链接] 
    发布者:欧洲临床微生物学会等
    发布时间:2023-05-13

2. 台湾COVID-19相关细菌和真菌感染的诊断和管理建议和指南
    Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan
    [原文链接] 
    发布者:台湾循证抗菌药物使用指南推荐 (GREAT) 工作组
    发布时间:2022-12-21

3. 2022 共识声明:COVID-19相关肺毛霉菌病的定义,诊断和管理
    Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India
    [原文链接] 
    发布者:国外呼吸科专家组
    发布时间:2022-04-04

4. 2021 ECMM/ISHAM建议:中低收入国家COVID -19相关毛霉菌病的管理
    ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries
    [原文链接]
    发布者:欧洲医学真菌学联盟(ECMM,European Confederation of Medical Mycology),国际人类和动物真菌学学会(ISHAM,International Society for Human and Animal Mycology)
    发布时间:2021-09-05

5. 2020年ECMM ISHAM COVID-19相关肺曲霉病定义及治疗共识
    Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
    [原文链接]
    发布者:欧洲医学真菌学联盟(ECMM,European Confederation of Medical Mycology),国际人类和动物真菌学学会(ISHAM,International Society for Human and Animal Mycology)
    发布时间:2020-12-14

6. 成人 COVID-19 抗菌治疗的建议-循证指南
    Recommendations for antibacterial therapy in adults with COVID-19 - an evidence based guideline
    [原文链接]
    发布者:荷兰抗生素政策工作组
    发布时间:2020-10-01

7. 关于重症新型冠状病毒肺炎继发侵袭性真菌感染实验室诊治建议
    [原文链接] 
    发布者:中国皮肤性病相关专家小组(统称)
    发布时间:2020-04-09

(有效期至2025-06-28)

以上医学资讯内容仅限于以学术参考/医学为目的的个人使用。

我们不推荐将辉瑞公司产品用于国家药品监督管理局批准的药品处方信息以外的用途。

如果您有任何问题,欢迎通过辉瑞医学信息网站在线提问联系我们。